IGFBP3 and breast carcinoma: A meta-analysis of 21 case-control studies including 3,609 cases and 7,137 controls has found that high concentrations of IGF1 and IGFBP3 were associated with an increased risk of incident breast cancer among premenopausal women but not among postmenopausal women (8).